In September of 2005, Council for Responsible Nutrition (CRN) senior vice president of scientific and international affairs, John Hathcock, PhD, wrote a letter to the FDA stating that “Pyridoxamine is unequivocally a dietary ingredient because it is one of the three primary natural forms of vitamin B6, and it is one of the two predominant… Continue reading When is a Vitamin Not a Vitamin? When the FDA Says So!
Tag: “Catch 22”
Council for Comparative Effectiveness Research
Columnist George Will in the January 29 issue of the Washington Post first noted that “The stimulus legislation creates a council for Comparative Effectiveness Research. This is about medicine but not about healing the economy. The CER would identify (this is language from the draft report on the legislation) medical ‘items, procedures, and interventions’ that… Continue reading Council for Comparative Effectiveness Research
FDA, Time to Follow Your Own Rules and Respond to the Citizens for Health Petition regarding Splenda
The FDA has a petition pending before it. It is FDA Docket No. 2006P-0158. The petition was filed on April 7, 2006, by Citizens for Health. The FDA acknowledged the petition the day it was filed. The petition asked that the FDA revoke its approval of sucralose (also known as Splenda).
Treating Brain Injured Iraq War Veterans
A safe, effective treatment exists for Iraq war veterans who have suffered brain injury. This treatment is called HBOT and delivers a powerful dose of oxygen to the brain.
FDA Roadblocks Scientific Revolution in Food and Food Supplements
Everyone — except the FDA — seems to know that a scientific revolution is taking place at the intersection of food, food extracts, and food supplements. Solid, peer reviewed scientific research is pouring forth from reputable research institutions, especially research universities such as Harvard, Stanford, and the like. This research suggests that changes in diet… Continue reading FDA Roadblocks Scientific Revolution in Food and Food Supplements
Compounding Medicine – Victory
U.S. District Court Judge Robert Junell ruled on August 30 that “it is in the best interest of public health” to uphold the legality of compounded drugs. In the past, FDA had proposed that, even though it is impossible to do so, compounded medicines must meet the same new drug requirements to which mass produced,… Continue reading Compounding Medicine – Victory